Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.

Kruser TJ, Jarrard DF, Graf AK, Hedican SP, Paolone DR, Wegenke JD, Liu G, Geye HM, Ritter MA.

Cancer. 2011 Jun 15;117(12):2629-36. doi: 10.1002/cncr.25824. Epub 2010 Dec 14.

2.

Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.

Wong GW, Palazzi-Churas KL, Jarrard DF, Paolone DR, Graf AK, Hedican SP, Wegenke JD, Ritter MA.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):449-55. Epub 2007 Sep 14.

PMID:
17869014
3.

Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):112-8. doi: 10.1016/j.ijrobp.2011.10.077. Epub 2012 Jan 31.

PMID:
22300563
4.

11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity.

Alongi F, Liardo RL, Iftode C, Lopci E, Villa E, Comito T, Tozzi A, Navarria P, Ascolese AM, Mancosu P, Tomatis S, Bellorofonte C, Arturo C, Scorsetti M.

Technol Cancer Res Treat. 2014 Oct;13(5):395-401. doi: 10.7785/tcrtexpress.2013.600268. Epub 2013 Aug 31.

5.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
6.

Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.

Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K.

Scand J Urol. 2015 Jun;49(3):218-23. doi: 10.3109/21681805.2014.982168. Epub 2014 Nov 27.

PMID:
25428750
7.

Identifying appropriate patients for early salvage radiotherapy after prostatectomy.

Karlin JD, Koontz BF, Freedland SJ, Moul JW, Grob BM, Wan W, Hagan MP, Anscher MS, Moghanaki D.

J Urol. 2013 Oct;190(4):1410-5. doi: 10.1016/j.juro.2013.04.078. Epub 2013 May 3.

PMID:
23648223
8.

Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.

Lee LW, McBain CA, Swindell R, Wylie JP, Cowan RA, Logue JP.

Clin Oncol (R Coll Radiol). 2004 Dec;16(8):517-22.

PMID:
15630843
9.

Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.

Lewis SL, Patel P, Song H, Freedland SJ, Bynum S, Oh D, Palta M, Yoo D, Oleson J, Salama JK.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):605-11. doi: 10.1016/j.ijrobp.2015.11.025. Epub 2015 Dec 2.

PMID:
26867889
10.

Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.

Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.

Cancer J Sci Am. 1998 Sep-Oct;4(5):324-30.

PMID:
9815297
11.

¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.

D'Angelillo RM, Sciuto R, Ramella S, Papalia R, Jereczek-Fossa BA, Trodella LE, Fiore M, Gallucci M, Maini CL, Trodella L.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):296-302. doi: 10.1016/j.ijrobp.2014.05.050. Epub 2014 Jul 29.

PMID:
25084612
12.

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W.

Radiother Oncol. 2008 Nov;89(2):205-13. doi: 10.1016/j.radonc.2008.07.027. Epub 2008 Sep 2.

PMID:
18771809
13.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM.

JAMA. 2004 Mar 17;291(11):1325-32.

PMID:
15026399
14.
15.

Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.

Cozzarini C, Fiorino C, Deantoni C, Briganti A, Fodor A, La Macchia M, Noris Chiorda B, Rancoita PM, Suardi N, Zerbetto F, Calandrino R, Montorsi F, Di Muzio N.

Eur Urol. 2014 Dec;66(6):1024-30. doi: 10.1016/j.eururo.2014.06.012. Epub 2014 Jun 27.

PMID:
24985964
16.
17.

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.

Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):269-76.

PMID:
12023129
18.

Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.

Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y, Ito K, Kiriu H, Ito A.

Int J Clin Oncol. 2007 Feb;12(1):37-41. Epub 2007 Feb 25.

PMID:
17380439
19.

Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.

Wahart A, Guy JB, Vallard A, Geissler B, Ben Mrad M, Falk AT, Prevot N, de Laroche G, Rancoule C, Chargari C, Magné N.

Br J Radiol. 2016;89(1058):20150579. doi: 10.1259/bjr.20150579. Epub 2015 Dec 9.

20.

Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Eur Urol. 2011 Dec;60(6):1142-8. doi: 10.1016/j.eururo.2011.08.006. Epub 2011 Aug 12.

PMID:
21855208

Supplemental Content

Support Center